{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:37:11Z","timestamp":1792431431500,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001537","name":"The University of Auckland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001511","name":"Auckland Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001511","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidinnovations.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JID Innovations"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.xjidi.2024.100343","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T12:00:46Z","timestamp":1735041646000},"page":"100343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficient Dual Cas9 Nickase Correction of a Prevalent Pathogenic LAMB3 Variant for Junctional Epidermolysis Bullosa"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9481-4149","authenticated-orcid":false,"given":"Alex","family":"du Rand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3095-0122","authenticated-orcid":false,"given":"John","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6060-0065","authenticated-orcid":false,"given":"Daniel","family":"Verdon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0320-8569","authenticated-orcid":false,"given":"Ben","family":"Buttle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9626-2600","authenticated-orcid":false,"given":"P. Rod","family":"Dunbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7511-7623","authenticated-orcid":false,"given":"Diana","family":"Purvis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3455-1201","authenticated-orcid":false,"given":"Vaughan","family":"Feisst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1147-4618","authenticated-orcid":false,"given":"Hilary","family":"Sheppard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xjidi.2024.100343_bib1","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jid.2016.10.038","article-title":"Closure of a large chronic wound through transplantation of gene-corrected epidermal stem cells","volume":"137","author":"Bauer","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.xjidi.2024.100343_bib2","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1016\/j.ymthe.2018.07.024","article-title":"CRISPR\/Cas9-mediated in situ correction of LAMB3 gene in keratinocytes derived from a junctional epidermolysis bullosa patient","volume":"26","author":"Benati","year":"2018","journal-title":"Mol Ther"},{"key":"10.1016\/j.xjidi.2024.100343_bib3","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.jid.2023.10.035","article-title":"Highly efficient ex vivo correction of COL7A1 through ribonucleoprotein-based CRISPR\/Cas9 and homology-directed repair to treat recessive dystrophic epidermolysis bullosa","volume":"144","author":"Berthault","year":"2024","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.xjidi.2024.100343_bib4","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/mt.2011.289","article-title":"Retroviral integrations in gene therapy trials","volume":"20","author":"Biasco","year":"2012","journal-title":"Mol Ther"},{"key":"10.1016\/j.xjidi.2024.100343_bib5","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.3390\/ijms25042243","article-title":"Emerging gene therapeutics for epidermolysis bullosa under development","volume":"25","author":"Bischof","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.xjidi.2024.100343_bib38","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1016\/j.ymthe.2022.04.020","article-title":"Paired nicking-mediated COL17A1 reframing for junctional epidermolysis bullosa","volume":"30","author":"Bischof","year":"2022","journal-title":"Mol Ther"},{"key":"10.1016\/j.xjidi.2024.100343_bib6","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.ymthe.2021.02.019","article-title":"Correction of recessive dystrophic epidermolysis bullosa by homology-directed repair-mediated genome editing","volume":"29","author":"Bonafont","year":"2021","journal-title":"Mol Ther"},{"key":"10.1016\/j.xjidi.2024.100343_bib37","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ymthe.2019.03.007","article-title":"Clinically Relevant Correction of Recessive Dystrophic Epidermolysis Bullosa by Dual sgRNA CRISPR\/Cas9-Mediated Gene Editing","volume":"27","author":"Bonafont","year":"2019","journal-title":"Mol Ther"},{"key":"10.1016\/j.xjidi.2024.100343_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/0471143030.cb1909s41","article-title":"Three-dimensional tissue models of normal and diseased skin","author":"Carlson","year":"2008","journal-title":"Curr Protoc Cell Biol"},{"key":"10.1016\/j.xjidi.2024.100343_bib8","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/j.celrep.2019.04.055","article-title":"Laminin 332-dependent YAP dysregulation depletes epidermal stem cells in junctional epidermolysis bullosa","volume":"27","author":"De Rosa","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.xjidi.2024.100343_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10640","article-title":"Highly efficient CRISPR\/Cas9-mediated exon skipping for recessive dystrophic epidermolysis bullosa","volume":"9","author":"du Rand","year":"2024","journal-title":"Bioeng Transl Med"},{"key":"10.1016\/j.xjidi.2024.100343_bib10","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s40291-022-00613-2","article-title":"Epidermolysis bullosa: a review of the tissue-engineered skin substitutes used to treat wounds","volume":"26","author":"du Rand","year":"2022","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.xjidi.2024.100343_bib11","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jcyt.2022.09.003","article-title":"Rapid culture of human keratinocytes in an autologous, feeder-free system with a novel growth medium","volume":"25","author":"Feisst","year":"2023","journal-title":"Cytotherapy"},{"key":"10.1016\/j.xjidi.2024.100343_bib12","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jaad.2008.02.004","article-title":"The classification of inherited epidermolysis bullosa (EB): report of the Third International Consensus Meeting on Diagnosis and Classification of EB","volume":"58","author":"Fine","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2024.100343_bib13","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s41591-022-01737-y","article-title":"In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial","volume":"28","author":"Gurevich","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.xjidi.2024.100343_bib14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature24487","article-title":"Regeneration of the entire human epidermis using transgenic stem cells","volume":"551","author":"Hirsch","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.xjidi.2024.100343_bib15","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00439-023-02561-1","article-title":"Unintended CRISPR-Cas9 editing outcomes: a review of the detection and prevalence of structural variants generated by gene-editing in human cells","volume":"142","author":"Hunt","year":"2023","journal-title":"Hum Genet"},{"key":"10.1016\/j.xjidi.2024.100343_bib16","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/mt.2009.144","article-title":"Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity","volume":"17","author":"Kern","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.xjidi.2024.100343_bib17","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1101\/gr.171322.113","article-title":"Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins","volume":"24","author":"Kim","year":"2014","journal-title":"Genome Res"},{"key":"10.1016\/j.xjidi.2024.100343_bib18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4161\/cam.22418","article-title":"Laminin 332 in junctional epidermolysis bullosa","volume":"7","author":"Kiritsi","year":"2013","journal-title":"Cell Adh Migr"},{"key":"10.1016\/j.xjidi.2024.100343_bib19","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.ymthe.2024.03.006","article-title":"On- and off-target effects of paired CRISPR-Cas nickase in primary human cells","volume":"32","author":"Klermund","year":"2024","journal-title":"Mol Ther"},{"key":"10.1016\/j.xjidi.2024.100343_bib20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.omtn.2021.05.015","article-title":"A non-viral and selection-free COL7A1 HDR approach with improved safety profile for dystrophic epidermolysis bullosa","volume":"25","author":"Kocher","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.xjidi.2024.100343_bib21","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1016\/j.ymthe.2017.08.015","article-title":"Cut and paste: efficient homology-directed repair of a dominant negative KRT14 mutation via CRISPR\/Cas9 nickases","volume":"25","author":"Kocher","year":"2017","journal-title":"Mol Ther"},{"key":"10.1016\/j.xjidi.2024.100343_bib22","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.omtn.2019.09.011","article-title":"Improved double-nicking strategies for COL7A1-editing by homologous recombination","volume":"18","author":"Kocher","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.xjidi.2024.100343_bib23","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1056\/NEJMoa2108544","article-title":"Transgenic epidermal cultures for junctional epidermolysis bullosa - 5-year outcomes","volume":"385","author":"Kueckelhaus","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xjidi.2024.100343_bib24","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/nm1504","article-title":"Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells","volume":"12","author":"Mavilio","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.xjidi.2024.100343_bib25","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.molcel.2021.12.026","article-title":"CRISPR-based genome editing through the lens of DNA repair","volume":"82","author":"Nambiar","year":"2022","journal-title":"Mol Cell"},{"key":"10.1016\/j.xjidi.2024.100343_bib26","doi-asserted-by":"crossref","first-page":"7402","DOI":"10.1093\/nar\/gkz459","article-title":"Microhomologies are prevalent at Cas9-induced larger deletions","volume":"47","author":"Owens","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.xjidi.2024.100343_bib39","doi-asserted-by":"crossref","first-page":"E10745","DOI":"10.1073\/pnas.1711979114","article-title":"Precision genome editing using synthesis-dependent repair of Cas9-induced DNA breaks","volume":"114","author":"Paix","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.xjidi.2024.100343_bib27","article-title":"COL17A1 editing via homology-directed repair in junctional epidermolysis bullosa","volume":"9","author":"Petkovi\u0107","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.xjidi.2024.100343_bib28","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/s41592-023-01949-1","article-title":"Efficient high-precision homology-directed repair-dependent genome editing by HDRobust","volume":"20","author":"Riesenberg","year":"2023","journal-title":"Nat Methods"},{"key":"10.1016\/j.xjidi.2024.100343_bib29","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4161\/cam.23132","article-title":"Laminin 332 processing impacts cellular behavior","volume":"7","author":"Rousselle","year":"2013","journal-title":"Cell Adh Migr"},{"key":"10.1016\/j.xjidi.2024.100343_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-98965-y","article-title":"Optimized design parameters for CRISPR Cas9 and Cas12a homology-directed repair","volume":"11","author":"Schubert","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.xjidi.2024.100343_bib31","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/bjd.13945","article-title":"A COL7A1 variant leading to in-frame skipping of exon 15 attenuates disease severity in recessive dystrophic epidermolysis bullosa","volume":"173","author":"Schwieger-Briel","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2024.100343_bib32","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1084\/jem.20171626","article-title":"Optimized RNP transfection for highly efficient CRISPR\/Cas9-mediated gene knockout in primary T cells","volume":"215","author":"Seki","year":"2018","journal-title":"J Exp Med"},{"key":"10.1016\/j.xjidi.2024.100343_bib33","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.jid.2019.02.015","article-title":"Efficient gene reframing therapy for recessive dystrophic epidermolysis bullosa with CRISPR\/Cas9","volume":"139","author":"Takashima","year":"2019","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.xjidi.2024.100343_bib34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nbt.3117","article-title":"GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases","volume":"33","author":"Tsai","year":"2015","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.xjidi.2024.100343_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/npjregenmed.2016.14","article-title":"CRISPR\/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosa","volume":"1","author":"Webber","year":"2016","journal-title":"NPJ Regen Med"}],"container-title":["JID Innovations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667026724000912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667026724000912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T22:36:01Z","timestamp":1762641361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667026724000912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S2667026724000912"],"URL":"https:\/\/doi.org\/10.1016\/j.xjidi.2024.100343","relation":{},"ISSN":["2667-0267"],"issn-type":[{"value":"2667-0267","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficient Dual Cas9 Nickase Correction of a Prevalent Pathogenic LAMB3 Variant for Junctional Epidermolysis Bullosa","name":"articletitle","label":"Article Title"},{"value":"JID Innovations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xjidi.2024.100343","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}],"article-number":"100343"}}